1-2b revenue with cogs at 5% leaving the rest as profit.
clearly once this hits the market the company will be earning appro 1B US per annum. Factor in a discount for time and 50% for success we are clearly still way undervalued. Wait until the US works this out!
Note, there will be more drugs and a platform to add to the value of the company. I dont think I have enough, again!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.030(2.11%) |
Mkt cap ! $828.2M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.37 | $19.07K | 13.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1247 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 1831 | 2 |
View Market Depth
| Last trade - 10.25am 23/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |